Showing results (1921-1930 of 2,166) with videos related to

Sort By:
Pageof 217
Leukemia|July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemiaJ E Lancet, F Ravandi, R M Ricklis, et al.
Endocrinology|February 3, 2007
Identification of the glomerular podocyte as a target for growth hormone actionGaddameedi R Reddy, Mary J Pushpanathan, Richard F Ransom, et al.
Leukemia Research|July 30, 2019
Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)Seongseok Yun, Rohit Sharma, Onyee Chan, et al.
Anesthesiology|April 29, 2006
Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosageAshraf A Dahaba, Seth I Perelman, David M Moskowitz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium studyS Mani, J W Kugler, D F Sciortino, et al.
Acta Haematologica|April 19, 2013
B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literatureJanese Trimaldi, Estrella M Carballido, Jeremy W Bowers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 9, 2007
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scoresSusan Yount, Marcy List, Hongyan Du, et al.
Leukemia & Lymphoma|February 25, 2020
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1Lynh Nguyen, Xiaohui Zhang, Evans Roberts, et al.
American Journal of Hematology|October 24, 2012
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromesRami S Komrokji, Maria Corrales-Yepez, Mohamed A Kharfan-Dabaja, et al.
Cell Host & Microbe|April 3, 2024
Diurnal rhythmicity of infant fecal microbiota and metabolites: A randomized controlled interventional trial with infant formulaNina Heppner, Sandra Reitmeier, Marjolein Heddes, et al.
Pageof 217